These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11433194)

  • 1. Activity of cysteine protease inhibitors in human brain tumors.
    Berdowska I; Siewiński M; Zarzycki-Reich A; Jarmułowicz J; Noga L
    Med Sci Monit; 2001; 7(4):675-9. PubMed ID: 11433194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of cysteine proteases and their inhibitors in the lymph nodes of larynx cancer patients.
    Siewiński M; Berdowska I; Mikulewicz W; Wnukiewicz J; Gutowicz J
    Med Sci Monit; 2002 Dec; 8(12):BR540-4. PubMed ID: 12503033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cysteine protease inhibitors in human gliomas and meningiomas.
    Sivaparvathi M; McCutcheon I; Sawaya R; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1996 Sep; 14(4):344-50. PubMed ID: 8878408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression.
    Calkins CC; Sloane BF
    Biol Chem Hoppe Seyler; 1995 Feb; 376(2):71-80. PubMed ID: 7794528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity.
    Amberger VR; Hensel T; Ogata N; Schwab ME
    Cancer Res; 1998 Jan; 58(1):149-58. PubMed ID: 9426071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
    Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain cysteine proteinase inhibitors II: evidence that a 21-kDa papain-binding component resembles ras p21.
    Berg MJ; Marks N
    J Neurosci Res; 1991 Oct; 30(2):391-7. PubMed ID: 1798057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues.
    Zengin E; Atukeren P; Kokoglu E; Gumustas MK; Zengin U
    Clin Neurol Neurosurg; 2009 May; 111(4):345-51. PubMed ID: 19117666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA synthesis activity and growth fractions of brain tumors].
    Kunz J; Schmidt A; Jänisch W
    Acta Histochem Suppl; 1992; 42():165-70. PubMed ID: 1584961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
    Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
    Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W; Papierz W; Szymczak W; Goraj B
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cathepsin S cysteine protease in human brain tumour microdialysates in vivo.
    Flannery T; McConnell RS; McQuaid S; McGregor G; Mirakhur M; Martin L; Scott C; Burden R; Walker B; McGoohan C; Johnston PG
    Br J Neurosurg; 2007 Apr; 21(2):204-9. PubMed ID: 17453790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrospinal fluid and plasma aminograms in patients with primary and secondary tumors of the CNS].
    Piek J; Adelt T; Huse K; Bock WJ
    Infusionsther Klin Ernahr; 1987 Apr; 14(2):73-7. PubMed ID: 3610311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM23 methylation and expression analysis in brain tumors.
    Costa FF; Colin C; Shinjo SM; Zanata SM; Marie SK; Sogayar MC; Camargo AA
    Neurosci Lett; 2005 Jun; 380(3):260-4. PubMed ID: 15862898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic analysis of ACNU in brain tumors (author's transl)].
    Hara M; Takeuchi K
    No To Shinkei; 1979 Dec; 31(12):1289-93. PubMed ID: 526372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3.
    Ray SK; Patel SJ; Welsh CT; Wilford GG; Hogan EL; Banik NL
    J Neurosci Res; 2002 Jul; 69(2):197-206. PubMed ID: 12111801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intraperitoneal tumor growth of human ovarian cancer cells by bi- and trifunctional inhibitors of tumor-associated proteolytic systems.
    Krol J; Kopitz C; Kirschenhofer A; Schmitt M; Magdolen U; Krüger A; Magdolen V
    Biol Chem; 2003 Jul; 384(7):1097-102. PubMed ID: 12956426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
    Mai J; Sameni M; Mikkelsen T; Sloane BF
    Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.